MENU
+Compare
TNXP
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$9.17
Change
-$0.50 (-5.17%)
Capitalization
51.26M

TNXP Tonix Pharmaceuticals Holding Corp Forecast, Technical & Fundamental Analysis

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TNXP with price predictions
Feb 21, 2025

Momentum Indicator for TNXP turns negative, indicating new downward trend

TNXP saw its Momentum Indicator move below the 0 level on February 03, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator turned negative. In of the 72 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TNXP turned negative on February 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at .

TNXP moved below its 50-day moving average on February 03, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TNXP crossed bearishly below the 50-day moving average on February 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TNXP broke above its upper Bollinger Band on January 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TNXP entered a downward trend on January 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for TNXP's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where TNXP advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.691) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). TNXP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.141) is also within normal values, averaging (251.218).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TNXP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TNXP is expected to report earnings to rise 1,600.00% to -391 cents per share on March 17

Tonix Pharmaceuticals Holding Corp TNXP Stock Earnings Reports
Q4'24
Est.
$-3.91
Q3'24
Beat
by $2.70
Q2'24
Missed
by $14.05
Q1'24
Beat
by $3.04
Q4'23
Est.
$-6.85
The last earnings report on November 12 showed earnings per share of -23 cents, beating the estimate of -293 cents. With 616.87K shares outstanding, the current market capitalization sits at 51.26M.
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACCS10.000.30
+3.09%
ACCESS Newswire Inc
NOC447.969.85
+2.25%
Northrop Grumman Corp
TENB38.37-0.16
-0.42%
Tenable Holdings
BBCP6.65-0.40
-5.67%
Concrete Pumping Holdings
CDE5.46-0.64
-10.49%
Coeur Mining

TNXP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with ICU. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then ICU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-5.17%
ICU - TNXP
77%
Closely correlated
-4.37%
TOVX - TNXP
35%
Loosely correlated
-3.73%
CRVS - TNXP
32%
Poorly correlated
-4.99%
RNAZ - TNXP
28%
Poorly correlated
-13.82%
ACET - TNXP
28%
Poorly correlated
-2.66%
More

Groups containing TNXP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-5.17%
TNXP
(2 stocks)
100%
Closely correlated
-4.77%